| April 1, 2007 |
|
Acceptance Period Extended |
CMS
In July 2006, the Form CMS-1500 (12-90) was revised by the National Uniform Claim Committee (NUCC)
predominantly for the purpose of accommodating the National Provider Identifier. Since that time,
the industry has been preparing for the implementation of the revised Form CMS-1500 (08-05). In
September 2006, Medicare announced that it would implement the revised Form CMS-1500 (08-05) on
January 01, 2007 with dual acceptability of both versions until March 31, 2007. Medicare further
announced that beginning April 01, 2007, the only acceptable version of the form would be the Form
CMS-1500 (08-05) and that the prior version, Form CMS-1500 (12-90), would be rejected.
The GPO has determined that the source files they received from the NUCC’s authorized forms
designer were improperly formatted.
Given the circumstances, CMS has decided to extend the acceptance period of the Form CMS-1500
(12-90) version beyond the original April 1, 2007 deadline while this situation is resolved.
Medicare contractors will be directed to continue to accept the Form CMS-1500 (12-90) until
notified by CMS to cease. At present, CMS is targeting June 1, 2007 as that date.
|
Correction |
CMS
Correction to CR5404: New Waived Tests
Transmittal: 1197 (PDF).
Effective Date: March 09, 2007
Improvement Amendments of 1988 (CLIA), contained an incorrect CPT for the Gryphus Diagnostics BVBlue test. In
both the table in the background section of the Recurring Update Notification attachment and in the waived test
list attachment, CR 5404 listed the CPT code for the Gryphus Diagnostics BVBlue as CPT Code: 87899QW.
The CPT code 87899 is for infectious agent activity detection tests by immunoassay with direct optical
observation; not otherwise specified. In contrast, the Gryphus Diagnostics BVBlue test is an enzyme activity test
that detects sialidase activity in vaginal fluid specimens and is not an immunoassay test. The code in this table
and in the waived test list attachment should have been 87999QW (Unlisted microbiology procedure). See the table
below for the correct codes.
Note: All the other information in CR 5404 remains the same.
|
| CPT Codes for FDA Approved New Waived Tests |
CPT Code/
Modifier |
Effective Date |
Description |
82274QW,
G0328QW |
June 15, 2006 |
Immunostics, Inc., hema-screen Specific Immunochemical Fecal Occult Blood Test |
| 87999QW |
June 30, 2006 |
Gryphus Diagnostics BVBlue |
| 83655QW |
September 18, 2006 |
ESA Biosciences LeadCare II Blood Lead Testing System (whole blood) |
|
|
Medically Unlikely Edits |
CMS
Medicare Matters: MM: 5495 (PDF).
Effective Date: April 01, 2007
In order to lower the Medicare fee-for-service paid claims error rate, the Centers for Medicare & Medicaid
Services (CMS) established units of service edits referred to below as Medically Unlikely Edits (MUEs). The
National Correct Coding Initiative (NCCI) contractor develops and maintains MUEs
Key Points
- The upcoming release of the next version of the MUEs, which is version 1.1.
- Medicare carriers and A/B MACs will deny the entire claim line from non-institutional providers
with units of service that exceed MUE criteria and pay the other services on the claims.
- FIs and A/B MACs will RTP claims from institutional providers with units of service that exceed
MUE criteria.
- An appeal process will not be allowed for RTP’ed claims as a result of an MUE. Instead, providers
should determine why the claim was returned, correct the error, and resubmit the corrected claim.
- Providers may appeal MUE criteria by forwarding a request the carrier or A/B MAC who, if they agree,
will forward the appeal to the National Correct Coding Contractor.
- Excess charges due to units of service greater than the MUE may not be billed to the beneficiary (this
is a “provider liability”), and this provision can neither be waived nor subject to an Advanced
Beneficiary Notice (ABN).
|
Quarterly Update to CCI Edits |
CMS
Version 13.1
Transmittal: 1201 (PDF).
Effective Date: April 01, 2007
These edits (Version 13.1), which include all previous versions and updates from January 1, 1996, will
be effective on April 1, 2007.
|
New Waived Tests |
CMS
New FDA Waived Tests Under CLIA
Transmittal: 1195 (PDF).
Effective Date: April 01, 2007
Implementation Date: April 02, 2007
- CPT/HCPCS code, 82042QW, has been assigned for the albumin test performed using the Abaxis Piccolo Point
of Care Chemistry Analyzer (Liver Panel Plus Reagent Disc){whole blood}.
- CPT/HCPCS code, 82150QW, has been assigned for the amylase test performed using the Abaxis Piccolo Point
of Care Chemistry Analyzer (Liver Panel Plus Reagent Disc){whole blood}.
- CPT/HCPCS code, 82247QW, has been assigned for the total bilirubin test performed using the Abaxis Piccolo
Point of Care Chemistry Analyzer (Liver Panel Plus Reagent Disc){whole blood}.
- CPT/HCPCS code, 82977QW, has been assigned for the gamma glutamlytransferase (GGT) test performed using
the Abaxis Piccolo Point of Care Chemistry Analyzer (Liver Panel Plus Reagent Disc){whole blood}.
- CPT/HCPCS code, 84075QW, has been assigned for the alkaline phosphatase test performed using the Abaxis
Piccolo Point of Care Chemistry Analyzer (Liver Panel Plus Reagent Disc){whole blood}.
- CPT/HCPCS code, 84157QW, has been assigned for the total protein test performed using the Abaxis Piccolo
Point of Care Chemistry Analyzer (Liver Panel Plus Reagent Disc){whole blood}.
- CPT/HCPCS code, 84520QW, has been assigned for the urea (BUN) test performed using the Arkray SPOTCHEM
EZ Chemistry Analyzer.
|
| Latest FDA Waived Tests Under CLIA* |
CPT Code/
Modifier |
Effective Date |
Description |
84450QW
and
84460QW |
August 16, 2005 |
Abaxis Piccolo Point of Care Chemistry Analyzer (Liver Panel Plus Reagent Disc){whole blood} |
| 87899QW |
March 30, 2006 |
Rapid Pathogen Screening RPS Adeno Detector |
| 86308QW |
July 27, 2006 |
PerMaxim RediScreen Mononucleosis {Whole Blood} |
| 82274QW, G0328QW |
August 03, 2006 |
Enterix Insure II Fecal Immunochemical Test |
| 82274QW, G0328QW |
August 09, 2006, |
Teco Rapid Fecal Occult Blood (FOB) Card Test |
82274QW, G0328QW |
September 22, 2006 |
OcculTech Fecal Occult Blood Rapid Test |
82042QW,
82150QW,
82247QW,
82977QW,
84075QW,
and
84157QW |
October 04, 2006 |
Abaxis Piccolo Point of Care Chemistry Analyzer (Liver Panel Plus Reagent Disc){whole blood} |
| 84520QW |
October 04, 2006 |
Arkray SPOTCHEM EZ Chemistry Analyzer{whole blood} for urea (BUN) |
| 84450QW |
October 05, 2006 |
Arkray SPOTCHEM EZ Chemistry Analyzer{whole blood} for aspirate amminotransferase (AST)(SGOT) |
| 85018QW |
October 10, 2006 |
HemoCue Hb 301 System |
| 87999QW |
October 16, 2006 |
Genzyme Diagnostics OSOM BVBlue Test |
| 87880QW |
November 01, 2006 |
Inverness Medical BioStar Acceava Strep A Test |
| 80101QW |
November 14, 2006 |
Branan Medical Corporation, QuickTox Drug Screen Dipcard |
| 80101QW |
November 14, 2006 |
Branan Medical Corporation, FasTox Multiple Drug Dipcard |
| 86308QW |
November 22, 2006 |
LifeSign Status Mono {for whole blood} |
*The Current Procedural Terminology (CPT) codes for these new tests must have the modifier QW
to be recognized as a waived test.
|
| |
| Waived Tests That Do Not Require the QW Modifier |
| CPT Codes |
Test Name |
Manufacturerr |
Description |
| 81002 |
Dipstick or tablet reagent urinalysis - non-automated for bilirubin,
glucose, hemoglobin, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen |
Various |
Screening of urine to monitor/diagnose various diseases/conditions, such as diabetes,
the state of the kidney or urinary tract, and urinary tract infections |
| 81025 |
Urine pregnancy tests by visual color comparison |
Various |
Diagnosis of pregnancy |
82270
82272
G0394
(Contact your Medicare carrier for claims instructions.) |
Fecal occult blood |
Various |
Detection of blood in feces from whatever cause, benign or malignant (colorectal cancer screening) |
| 82962 |
Blood glucose by glucose monitoring devices cleared by the FDA
for home use |
Various |
Monitoring of blood glucose levels |
| 83026 |
Hemoglobin by copper sulfate - non-automated |
Various |
Monitors hemoglobin level in blood |
| 84830 |
Ovulation tests by visual color comparison for human luteinizing hormone |
Various |
Detection of ovulation (optimal for conception) |
| 85013 |
Blood count; spun microhematocrit |
Various |
Screen for anemia |
| 85651 |
Erythrocyte sedimentation rate - non-automated |
Various |
Nonspecific screening test for inflammatory activity, increased for majority
of infections, and most cases of carcinoma and leukemia |
|
NCD Edits |
CMS
Laboratory National Coverage Determination (NCD) Edits
Transmittal: 1200.
Effective: Dates of Service on or After April 01, 2007
The new HCPCS code G0394 for Blood occult test (e.g., guaiac), feces, for single determination for
colorectal neoplasm (i.e., patient was provided three cards or single triple card for consecutive
collection) is added to the list of HCPCS codes for the Fecal Occult Blood Test NCD (190.34).
|
| |
Claims Adjudication Claims Adjudication |
NHIC — California
Error for “10” Units Corrected
The NHIC Medicare Claims Adjudication system was incorrectly processing claims for procedure codes 83898,
83901, 88180, 88185, 88271, 88275, 88305, 88312, 88313, 88342, 88358, 88360, 88361, 88365 and 88368 when
ordered with “10 units” by processing the claims for “1 unit”, causing providers to
have to appeal these claims in order to obtain the appropriate reimbursement. This system error was corrected
by NHIC EDI on February 26, 2007. NHIC is unable to automatically correct the miss-paid claims, because of
their inability to identify the claims which appear to be properly paid in their system. Accordingly, Providers
who still have improperly paid claims may request a reopening to obtain payment on the remaining unpaid 9 units.
|